≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified diseases of spleen

DOID EFO Endpoint Browser PheWeb

D3_SPLEENNAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D73.8, D73.9
  • Hospital discharge: ICD-9 — 2895A
  • Hospital discharge: ICD-8 — 2894
  • Hospital discharge: excluded ICD-8 — 28940|28942
  • Cause of death: ICD-10 — D73.8, D73.9
  • Cause of death: ICD-9 — 2895A
  • Cause of death: ICD-8 — 2894
  • Cause of death: excluded ICD-8 — 28940|28942

2 out of 7 registries used, show all original rules.

145

4. Check minimum number of events

None

145

5. Include endpoints

None

145

6. Filter based on genotype QC (FinnGen only)

145

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 905 489 409
Only index persons 758 427 331
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.02 0.01
Median age at first event (years)
Whole population 58.59 60.01 56.88
Only index persons 56.10 56.89 55.07

-FinnGen-

Key figures

All Female Male
Number of individuals 145 77 68
Unadjusted period prevalence (%) 0.03 0.03 0.03
Median age at first event (years) 57.33 56.66 58.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
132
Matched controls
1320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D73.9
ICD-10 Finland
Disease of spleen, unspecified
+∞
87.5
74
*
D73.8
ICD-10 Finland
Other diseases of spleen
+∞
55.1
49
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
145.3
23.4
24
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
+∞
14.9
14
*
XW000
NOMESCO Finland
Bone marrow biopsy
15.2
14.1
23
18
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
23.8
9.6
13
6
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
10.1
8.8
17
19
J01MA12
ATC
levofloxacin; systemic
3.9
8.8
39
127
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
8.5
34
100
D73.5
ICD-10 Finland
Infarction of spleen
+∞
8.4
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
7.5
54
248
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
84.6
7.5
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004588) Protein electrophoresis panel - Serum or Plasma
32
64
6.13
16.13
2.8
3.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
36
88
5.11
14.49
2.7
2.5
g/l
10.3
10.7
0.21
31
77
(3032080) INR in Blood by Coagulation assay
87
447
3.37
11.61
9.1
8.0
inr
1.2
1.2
0.28
32
138
(42870588) Differential panel, method unspecified - Blood
74
373
3.01
9.73
8.2
5.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
14
9.25
9.48
1.7
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
73
376
2.90
9.07
5.0
2.4
u/l
52.3
54.6
0.32
66
345
(3002179) Metamyelocytes/100 leukocytes in Blood
29
85
4.01
9.06
4.2
4.6
%
0.9
0.3
0.73
11
21
(3019198) Lymphocytes [#/volume] in Blood
96
580
2.94
8.71
8.0
6.1
e9/l
2.1
1.8
0.74
88
526
(3023368) Bacteria identified in Blood by Culture
61
293
2.87
8.53
6.2
4.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
7
18.52
8.22
1.8
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
95
582
2.83
8.20
9.0
6.3
e9/l
0.2
0.2
0.29
87
529
(3006315) Basophils [#/volume] in Blood
93
567
2.79
8.04
8.2
6.0
e9/l
0.0
0.0
0.24
84
505
(3001604) Monocytes [#/volume] in Blood
93
568
2.78
8.00
8.1
5.9
e9/l
0.6
0.6
1.47
84
505
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
87
516
2.72
7.90
9.0
3.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
90
543
2.73
7.89
16.0
6.5
mmol/l
1.2
1.2
0.31
69
459
(3017181) Myelocytes/100 leukocytes in Blood
30
100
3.52
7.74
4.6
4.5
%
0.7
0.9
0.25
16
35
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
136
3.19
7.61
1.6
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
46
202
2.87
7.46
1.9
1.7
nmol/l
1128.5
1148.7
0.05
38
154
(3021440) Promyelocytes/100 leukocytes in Blood
28
92
3.53
7.37
4.5
4.7
%
0.1
0.2
0.12
16
31
(3026493) Urate [Moles/volume] in Serum or Plasma
57
284
2.66
7.22
3.7
2.8
umol/l
7557.0
3443.3
0.23
49
243
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
38
157
2.92
6.83
3.7
2.4
%
22.5
23.2
0.09
33
136
(3037756) Immunofixation for Serum or Plasma
12
21
6.14
6.70
1.8
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
26
89
3.34
6.39
4.0
4.6
%
0.0
0.3
0.49
12
26
(1616796) Gas panel - Central venous blood
12
23
5.60
6.12
4.3
3.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
41
188
2.65
5.99
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
63
360
2.33
5.68
3.4
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
51
267
2.40
5.60
2.7
2.0
mg/l
4.4
3.1
1.93
43
231
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
78
490
2.28
5.59
13.9
5.6
mmol/l
1.2
1.2
0.70
70
448
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
49
253
2.41
5.54
1.5
1.8
mg/l
1.3
0.9
0.42
38
201
(4035726)
26
97
3.05
5.53
1.3
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
96
663
2.33
5.42
12.6
9.8
e9/l
4.1
4.1
0.06
87
590
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
18
5.89
5.40
3.8
3.6
%
51.8
55.4
—
10
18
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
26
99
2.98
5.34
2.5
2.5
g/l
0.2
0.2
0.40
26
92
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
67
404
2.22
5.21
3.8
3.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
83
3.10
5.16
1.3
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
35
159
2.58
5.15
1.3
1.4
titre
376.0
584.6
—
10
39
(40760888) Immunoglobulin light chains.free panel - Serum
10
19
5.58
5.12
3.3
6.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
50
270
2.30
5.04
6.9
5.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
19
66
3.16
4.53
4.8
2.9
kpa
5.3
5.1
0.34
19
59
(3030467) Casts [#/volume] in Urine by Automated count
54
318
2.11
4.30
3.6
3.2
e6/l
0.2
0.4
0.95
44
236
(3041096) Erythrocytes [Presence] in Urine by Automated
55
330
2.07
4.14
3.9
3.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
41
220
2.20
4.11
1.8
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
68
444
2.00
4.03
4.7
3.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
128
2.47
4.03
2.0
4.2
ug/l
4.5
4.7
0.02
21
108
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
114
899
2.25
3.97
13.6
7.3
u/l
81.4
75.6
0.89
108
846
(3042936) Bacteria identified in Isolate by Culture
32
159
2.30
3.83
2.8
2.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
50
3.23
3.81
4.7
2.4
%
1.1
1.4
0.29
15
50
(3022313) Gas panel - Capillary blood
14
45
3.34
3.76
4.4
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
267
2.06
3.73
3.3
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
30
3.89
3.71
1.2
2.1
—
—
—
0
0
(3019225) pH of Specimen
22
94
2.58
3.62
12.9
3.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
41
231
2.08
3.59
2.3
1.4
g/l
2.3
2.5
0.28
31
139
(3019060) Gas panel - Arterial blood
17
64
2.88
3.54
12.8
3.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
18
5.25
3.43
3.4
3.4
e9/l
4.1
4.0
—
9
18
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
37
3.45
3.42
1.9
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
66
445
1.89
3.42
2.5
2.0
pmol/l
86.3
96.3
1.33
43
235
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
19
4.98
3.29
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
104
821
1.94
3.21
4.1
2.9
u/l
67.5
47.0
0.77
94
779
(3013512) EKG study
52
330
1.90
3.21
4.9
3.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
50
314
1.90
3.18
3.3
2.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
31
164
2.13
3.17
1.3
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
61
409
1.85
3.16
4.1
3.9
e6/l
16.7
47.2
1.66
49
286
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
29
3.63
3.11
3.3
2.7
mmol/l
23.5
25.0
—
10
23
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
8
7.76
3.08
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
8
7.76
3.08
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
12
6.07
3.06
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
12
6.07
3.06
1.6
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
12
6.07
3.06
1.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
5
10.29
3.00
5.0
2.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
16
65
2.64
2.90
9.1
2.4
g/l
118.1
131.2
1.16
16
65
(3002582) Erythrocytes [#/volume] in Urine
54
357
1.82
2.88
3.8
3.3
e6/l
18.8
207.0
0.52
43
272
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
36
3.22
2.87
1.9
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
72
520
1.76
2.84
13.0
9.9
e9/l
0.0
0.0
0.24
58
430
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
42
3.02
2.82
4.1
2.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
42
3.02
2.82
4.1
2.9
g/l
2.9
3.9
—
6
33
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
42
3.02
2.82
4.1
2.9
g/l
6.1
7.9
—
6
35
(3002256) Pathology report gross observation
24
120
2.20
2.81
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
5
6
8.57
2.77
1.8
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
10
6.20
2.72
1.3
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
15
4.84
2.63
3.9
2.5
mmol/l
100.7
106.9
—
7
15
(3041354) Potassium [Moles/volume] in Venous blood
7
15
4.84
2.63
3.9
2.5
mmol/l
4.2
4.1
—
7
15
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
15
4.84
2.63
3.9
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
77
576
1.72
2.62
6.2
4.8
estimate
0.0
0.0
0.00
21
116
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
20
4.17
2.61
4.0
3.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
33
3.18
2.58
1.5
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
7
7.34
2.57
1.8
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
76
569
1.71
2.56
4.6
3.6
estimate
0.0
0.0
0.00
21
114
(3028707) Methadone [Presence] in Urine by Screen method
7
16
4.54
2.50
2.4
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
21
3.97
2.50
1.8
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
77
583
1.68
2.45
4.6
3.6
estimate
0.0
0.0
0.00
20
107
(3031040) Bacteria [#/volume] in Urine by Automated count
95
761
1.72
2.45
4.6
4.4
—
53.7
—
0
15
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
52
2.65
2.43
6.0
3.4
%
49.7
47.2
0.14
13
52
(40768795) Lymph node Pathology biopsy report
6
12
5.16
2.42
1.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
99
804
1.73
2.41
5.8
4.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
22
3.78
2.40
1.8
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
8
6.42
2.39
3.0
1.8
mg/l
6.3
4.0
—
5
8
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
8
6.42
2.39
1.0
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
106
879
1.77
2.37
6.3
4.2
mm/h
16.6
11.5
1.79
101
815
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
23
3.62
2.30
5.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
23
3.62
2.30
1.3
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
145
1.97
2.29
1.7
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
13
4.76
2.29
2.7
2.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
32
193
1.84
2.24
2.6
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
9
5.71
2.23
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
139
1.96
2.23
1.5
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
88
2.19
2.22
2.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
24
3.47
2.21
1.9
1.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
50
347
1.67
2.16
6.5
4.3
ph
7.4
7.4
0.06
18
67
(1761482) Bacteria [#/volume] in Urine by Culture
10
37
2.83
2.15
4.3
4.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
126
1.98
2.13
1.9
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
25
3.32
2.13
1.3
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
130
1163
2.14
2.10
29.1
13.6
mg/l
23.7
22.8
0.12
122
911
(40768804) Tissue Pathology biopsy report
60
440
1.62
2.08
2.4
2.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
15
4.12
2.06
1.0
1.5
ug/l
13.0
14.2
—
6
15
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
21
3.45
1.99
1.3
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
11
4.66
1.95
2.2
1.2
pg
33.2
33.2
—
5
11
(4062490)
5
11
4.66
1.95
1.6
1.2
—
—
—
0
0
(44790049)
6
16
3.86
1.95
1.7
2.0
—
—
—
0
0
(44790047)
6
16
3.86
1.95
1.7
2.0
—
—
—
0
0
(44790048)
6
16
3.86
1.95
1.7
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
16
3.86
1.95
1.2
1.2
—
—
—
0
0
(44806118)
6
16
3.86
1.95
1.7
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
44
303
1.65
1.94
4.8
4.0
estimate
0.0
0.0
0.00
18
109
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
52
0.00
1.92
0.0
1.9
—
6.4
—
0
35
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
62
466
1.58
1.90
3.2
2.4
nmol/l
69.9
76.7
1.17
55
422
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
28
2.96
1.89
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
17
87
2.08
1.89
9.4
7.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
124
1.91
1.89
5.8
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
102
862
1.62
1.87
5.5
3.9
pmol/l
14.8
14.8
0.01
94
794
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
12
4.27
1.84
1.0
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
52
378
1.59
1.83
7.1
3.1
mmol/l
2.3
2.3
0.09
47
334
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
29
2.86
1.82
1.3
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
16
82
2.07
1.77
1.8
2.8
e9/l
3.4
3.5
0.05
11
66
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
18
3.43
1.76
2.0
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
30
2.76
1.75
1.1
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
30
2.76
1.75
1.9
1.8
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
13
3.94
1.73
2.0
2.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
24
144
1.80
1.71
3.6
2.1
ug/g
424.6
112.9
0.45
18
117
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
19
3.25
1.68
1.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
26
2.78
1.60
5.3
2.5
mmol/l
6.8
7.3
—
7
26
(3021901) Oxygen saturation in Capillary blood
6
20
3.08
1.60
3.3
3.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
20
3.08
1.60
2.0
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
28
180
1.69
1.58
3.2
2.8
e6/l
1.5
0.7
0.60
16
103
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
15
3.41
1.53
1.4
1.6
nmol/l
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
15
3.41
1.53
1.8
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
46
337
1.53
1.53
3.0
3.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
121
1088
1.68
1.51
22.8
13.0
ml/min/173m2
79.2
81.5
0.45
97
894
(40761536) Microorganisms panel - Urine sediment
18
103
1.85
1.49
5.9
3.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
52
2.21
1.48
18.7
7.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
28
2.57
1.47
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
176
1.66
1.45
1.5
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
40
2.33
1.43
1.3
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
26
169
1.66
1.41
3.4
3.0
e6/l
5.5
2.3
0.68
13
94
(3008037) Lactate [Moles/volume] in Venous blood
7
29
2.48
1.41
5.3
2.3
mmol/l
1.4
1.5
—
7
29
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
61
2.05
1.37
1.9
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
17
3.01
1.37
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
17
3.01
1.37
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
17
3.01
1.37
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
17
3.01
1.37
1.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
54
2.12
1.37
1.3
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
62
2.02
1.32
5.4
3.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
48
2.16
1.31
2.5
2.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
18
2.84
1.29
1.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
18
2.84
1.29
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
44
2.11
1.29
1.9
1.9
—
—
—
0
0
(3020891) Body temperature
8
35
2.36
1.29
16.9
5.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
133
1.68
1.26
2.2
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
25
2.46
1.25
3.5
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
8
37
2.23
1.23
1.6
1.2
u/l
14.3
6.6
—
8
31
(3027944) Amphetamines [Presence] in Urine
8
37
2.23
1.23
2.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
37
2.23
1.23
2.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
37
2.23
1.23
2.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
37
2.23
1.23
2.3
1.4
—
—
—
0
0
(3012544) pH of Venous blood
18
110
1.73
1.22
9.6
2.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
143
1.63
1.20
4.3
4.4
%
35.6
31.2
0.98
17
97
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
26
2.36
1.20
1.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
26
2.36
1.20
1.0
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
91
788
1.42
1.20
5.0
3.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
112
0.43
1.19
1.2
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.55
1.16
1.2
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
40
2.06
1.14
2.3
2.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
14
81
1.81
1.13
4.9
3.5
ng/l
210.4
124.7
0.37
14
74
(4306422)
5
21
2.43
1.10
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
41
313
1.43
1.09
4.5
3.2
mg/l
1242.3
64.3
0.49
30
204
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
132
1240
1.72
1.05
17.0
10.0
u/l
26.1
25.9
0.06
126
1206
(21494755) Public health laboratory ask at order entry panel
7
134
0.50
1.05
1.1
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
35
2.05
1.01
2.4
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
38
291
1.41
0.99
7.4
7.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
35
264
1.43
0.99
1.2
1.3
u/ml
1.1
2.0
—
6
78
(3044290) Cell count panel - Cerebral spinal fluid
5
23
2.21
0.99
1.0
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
36
1.99
0.98
1.4
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
36
1.99
0.98
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
135
1.56
0.95
2.4
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
37
1.94
0.95
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
38
294
1.40
0.93
1.8
1.7
nmol/l
19.7
22.5
0.40
29
249
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
6
29
2.11
0.90
1.5
3.7
g/l
0.0
0.0
—
6
29
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
198
1.45
0.88
1.4
1.3
iu/ml
17.1
36.8
—
5
73
(3003694) ABO and Rh group [Type] in Blood
39
307
1.37
0.86
1.6
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
26
191
1.44
0.85
1.4
1.3
u/ml
1.1
6.9
—
7
77
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
55
460
1.32
0.82
5.8
3.6
ng/l
38.3
38.6
0.01
43
307
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
66
1.72
0.81
1.0
1.2
—
42.1
—
0
5
(3030981) Hyaline casts [#/volume] in Urine by Automated count
11
66
1.72
0.81
4.6
3.2
e6/l
0.2
0.1
0.39
11
61
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
116
1.53
0.78
13.9
8.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
83
1.62
0.78
3.7
4.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
41
332
1.33
0.76
5.7
4.0
mg/mmol
20.6
9.8
0.67
32
207
(42529406) Shigella sp [Presence] in Stool by Culture
7
38
1.88
0.75
1.3
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
29
223
1.38
0.74
5.2
3.5
ng/l
803.2
133.8
0.47
23
171
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
26
1.96
0.71
1.6
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
120
1.47
0.68
1.6
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
41
337
1.30
0.68
4.3
3.0
mmol/l
6.0
7.9
2.16
33
281
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
28
1.81
0.67
1.0
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
28
1.81
0.67
1.2
1.4
e6/l
2.0
12.9
—
5
21
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
28
1.81
0.67
1.2
1.5
e6/l
2.6
38.2
—
5
23
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
44
1.62
0.66
1.3
1.2
iu/l
39.9
24.5
—
7
37
(3026361) Erythrocytes [#/volume] in Blood
135
1299
1.57
0.64
42.2
19.9
e12/l
4.3
4.5
3.11
130
1268
(40761511) CBC panel - Blood by Automated count
128
1222
1.40
0.60
33.4
12.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
23
0.00
0.59
0.0
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
23
0.00
0.59
0.0
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
62
1.48
0.54
1.2
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
113
1066
1.27
0.54
6.5
4.5
mu/l
1.9
1.9
0.06
104
973
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
39
1.56
0.53
1.8
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
63
1.46
0.53
2.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
45
1.58
0.49
2.4
3.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
47
1.51
0.48
2.4
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
114
1082
1.25
0.47
25.3
14.1
%
37.2
40.5
1.87
76
804
(3045414) Leukocytes [Presence] in Urine
7
50
1.42
0.45
1.6
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
0
18
0.00
0.40
0.0
1.4
—
4520.4
—
0
12
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
27
319
0.81
0.39
1.8
1.6
mmol/l
2.8
1.4
0.78
22
267
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
2.4
—
15.1
—
0
19
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
41
1.48
0.36
1.5
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
118
1.30
0.35
2.1
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
29
249
1.21
0.34
4.6
3.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
47
1.29
0.32
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
62
1.31
0.28
1.5
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
113
1090
1.17
0.28
6.4
5.6
mmol/mol
41.5
39.7
0.71
99
1027
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
121
1174
1.19
0.27
5.1
4.8
mmol/l
2.5
2.8
1.74
108
1095
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
115
1113
1.16
0.26
4.5
3.9
mmol/l
1.5
1.3
1.59
101
1030
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
7.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
8.2
—
0
10
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
10
0.00
0.21
0.0
1.8
—
6.7
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
61
1.15
0.18
2.6
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
118
1156
1.11
0.15
4.6
4.4
mmol/l
4.4
4.7
2.03
107
1083
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
115
1127
1.10
0.13
5.2
4.4
mmol/l
6.1
5.9
0.58
103
1046
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
117
1149
1.09
0.12
4.7
4.4
mmol/l
1.3
1.5
3.78
104
1068
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
78
756
1.07
0.11
3.0
3.1
—
—
—
0
0
(3000492) Spirometry study
11
124
0.88
0.09
1.4
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
134
0.89
0.09
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
6
53
1.14
0.09
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
120
1.09
0.05
2.2
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
93
1.08
0.02
2.3
2.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
307
0.97
0.01
3.8
4.2
%
19.7
20.9
0.20
17
140
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
39
397
0.98
0.01
4.3
4.6
ug/l
2.7
3.1
0.17
33
358
(36660697) Celiac disease serology panel - Serum
10
99
1.01
0.00
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
22
224
0.98
0.00
3.7
2.9
ug/l
0.7
0.9
0.43
15
144
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
133
0.98
0.00
2.3
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
23
227
1.02
0.00
1.3
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
45
445
1.02
0.00
2.8
2.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
71
0.99
0.00
1.6
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
39.3
—
0
6
(4281824)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
0.9
—
0
9
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
9.0
—
0
7
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
61
0.98
0.00
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(4010399)
8
84
0.95
0.00
1.6
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
17.4
—
0
9
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_SPLEENNAS and mortality.

Females

Parameter HR [95% CI] p-value
D3_SPLEENNAS 3.05 [2.07, 4.49] < 0.001
Birth year 0.994 [0.99, 1.0] 0.19

During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 308 females with D3_SPLEENNAS died.

Males

Parameter HR [95% CI] p-value
D3_SPLEENNAS 2.705 [1.59, 4.59] < 0.001
Birth year 0.989 [0.98, 1.0] 0.017

During the follow-up period (1.1.1998 — 31.12.2019), 78 out of 259 males with D3_SPLEENNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_SPLEENNAS.

N-year risk Females Males
1 0.325% 0.504%
5 1.613% 2.996%
10 4.027% 8.117%
15 7.92% 15.309%
20 13.948% 25.008%

Relationships between endpoints

↥

Index endpoint: D3_SPLEENNAS – Other and unspecified diseases of spleen

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data